Safety and Efficacy of Autologous Cardiopoietic Cells for Treatment of Ischemic Heart Failure.
Clinical trial NCT01768702 · COMPLETED
Trial details
- NCT number
- NCT01768702
- Sponsor
- Celyad Oncology SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2017-08-01
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.